company background image
540395 logo

Chemcrux Enterprises BSE:540395 Stock Report

Last Price

₹168.35

Market Cap

₹2.5b

7D

-1.8%

1Y

-43.9%

Updated

03 Jan, 2025

Data

Company Financials

Chemcrux Enterprises Limited

BSE:540395 Stock Report

Market Cap: ₹2.5b

540395 Stock Overview

Engages in the manufacture and sale of intermediates and chemicals in India. More details

540395 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Chemcrux Enterprises Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Chemcrux Enterprises
Historical stock prices
Current Share Price₹168.35
52 Week High₹326.00
52 Week Low₹165.55
Beta0.66
1 Month Change-11.81%
3 Month Change-18.32%
1 Year Change-43.88%
3 Year Change-3.96%
5 Year Change480.52%
Change since IPO2,238.19%

Recent News & Updates

Recent updates

Shareholder Returns

540395IN ChemicalsIN Market
7D-1.8%1.2%1.8%
1Y-43.9%2.5%18.0%

Return vs Industry: 540395 underperformed the Indian Chemicals industry which returned 2.5% over the past year.

Return vs Market: 540395 underperformed the Indian Market which returned 18% over the past year.

Price Volatility

Is 540395's price volatile compared to industry and market?
540395 volatility
540395 Average Weekly Movement3.5%
Chemicals Industry Average Movement5.9%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 540395 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 540395's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198398Sanjaybhai Marathewww.chemcrux.com

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, aceturic acid, lassamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride.

Chemcrux Enterprises Limited Fundamentals Summary

How do Chemcrux Enterprises's earnings and revenue compare to its market cap?
540395 fundamental statistics
Market cap₹2.49b
Earnings (TTM)₹72.60m
Revenue (TTM)₹752.08m

34.3x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540395 income statement (TTM)
Revenue₹752.08m
Cost of Revenue₹316.65m
Gross Profit₹435.43m
Other Expenses₹362.84m
Earnings₹72.60m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.90
Gross Margin57.90%
Net Profit Margin9.65%
Debt/Equity Ratio37.8%

How did 540395 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

18%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 21:09
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chemcrux Enterprises Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution